{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:06:21Z","timestamp":1792033581867,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3631,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/modpathol.2012.165","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T07:58:09Z","timestamp":1348819089000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Leonardo","family":"Boiocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanny","family":"Espinal-Witter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Turbiner","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Steinhilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bonzheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.165_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"44","article-title":"Primary myelofibrosis","author":"Thiele","year":"2008"},{"key":"10.1038\/modpathol.2012.165_bib2","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib3","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2012.165_bib4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2012.165_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"76","article-title":"Chronic myelomonocytic leukaemia","author":"Orazi","year":"2008"},{"key":"10.1038\/modpathol.2012.165_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1309\/FU04P779U310R3EE","article-title":"Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease","volume":"126","author":"Wang","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2012.165_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.leukres.2006.11.013","article-title":"Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia\/lymphoma (ATLL)","volume":"31","author":"Takasaki","year":"2007","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2012.165_bib8","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00432-009-0625-1","article-title":"Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer","volume":"135","author":"Chen","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/modpathol.2012.165_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.leukres.2006.12.025","article-title":"Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis","volume":"31","author":"Elliott","year":"2007","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2012.165_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.seminhematol.2005.05.020","article-title":"Bone marrow histopathology in myeloproliferative disorders\u2013current diagnostic approach","volume":"42","author":"Thiele","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1038\/modpathol.2012.165_bib11","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2012.165_bib12","unstructured":"Shaffer LG, Slovak ML, Campbell LJ, (eds) ISCN (2009): an International System for Human Cytogenetic Nomenclature. Karger Basel, 2009."},{"key":"10.1038\/modpathol.2012.165_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2353\/jmoldx.2007.060133","article-title":"Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"9","author":"Chen","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2012.165_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bjc.6602319","article-title":"Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes","volume":"92","author":"Dabritz","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.165_bib15","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/cncr.23505","article-title":"Risk factors for leukemic transformation in patients with primary myelofibrosis","volume":"112","author":"Huang","year":"2008","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2012.165_bib16","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1182\/blood-2009-12-255943","article-title":"Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients","volume":"115","author":"Morel","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11899-011-0102-1","article-title":"Prognostication in primary myelofibrosis","volume":"7","author":"Cervantes","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1038\/modpathol.2012.165_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00428-009-0726-x","article-title":"The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia","volume":"454","author":"Qubaja","year":"2009","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2012.165_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/PAI.0b013e3182052805","article-title":"Comparative analysis of detecting monocytic cells and their aberrancy","volume":"19","author":"Dunphy","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2012.165_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2559.2012.04175.x","article-title":"The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias","volume":"60","author":"Rollins-Raval","year":"2012","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2012.165_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.2012.165_bib22","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-09-2112","article-title":"RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant","volume":"16","author":"Ricci","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.165_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.2009.065904","article-title":"JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia","volume":"62","author":"Pich","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2012.165_bib24","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2009-08-236596","article-title":"Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm","volume":"115","author":"Beer","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib25","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","article-title":"Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation","volume":"109","author":"Hussein","year":"2007","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood-2008-01-136499","article-title":"Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L\/JAK2V617F mutation","volume":"113","author":"Hussein","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib27","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood-2008-07-167056","article-title":"Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F","volume":"113","author":"Schaub","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.leukres.2009.09.016","article-title":"JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones","volume":"34","author":"Sokol","year":"2010","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2012.165_bib29","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2009-09-245381","article-title":"Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms","volume":"115","author":"Schaub","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib30","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood-2010-03-274704","article-title":"Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.165_bib31","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522203157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522203157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:07:06Z","timestamp":1760231226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522203157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S089339522203157X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.165","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}